Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0044200 PREPARATION METHOD FOR HIGH-PURITY 4'-GALACTOSYL-LACTOSE COMPOSITION
A composition which has high 4'-GL purity and can be used as a reference standard for various analyses can be obtained by a more convenient method than one...
2017/0044199 HAFNIUM-CONTAINING FILM FORMING COMPOSITIONS FOR VAPOR DEPOSITION OF HAFNIUM-CONTAINING FILMS
Disclosed are Hafnium-containing film forming compositions comprising Silicon- and Hafnium-containing precursors having one of the following formulae: ...
2017/0044198 TRANSITION METAL COMPLEXES FOR ENANTIOSELECTIVE CATALYSIS OF CARBON-CARBON, CARBON-HETEROATOM, AND...
In some embodiments, the present disclosure pertains to a compound, comprising a transition metal complex having the formula .PHI.-[M (x,y)-L.sub.1...
2017/0044197 ANTIMICROBIAL PREPARATION AND USES THEREOF
A method of enhancing the growth of an animal is provided. The method includes causing the animal to ingest or absorb an effective amount of a preparation...
2017/0044196 RUTHENIUM COMPLEX, METHOD FOR PRODUCING SAME, AND USE OF SAME
The present invention provides a novel ruthenium complex that is easy to produce and handle and that can be supplied relatively inexpensively, a method for...
2017/0044195 RUTHENIUM-BASED TRIAZOLE CARBENE COMPLEXES
The present invention relates to novel ruthenium-based triazole carbene complexes comprising specific ligands, their preparation and their use as catalysts in...
2017/0044194 Metal Complexes with Dibenzo[f,h]quinoxalines
This invention relates to electroluminescent metal complexes of the formula electronic devices comprising the metal complexes and their use in electronic...
2017/0044193 PENTAAZA MACROCYCLIC RING COMPLEXES POSSESSING ORAL BIOAVAILABILITY
Aspects of the present disclosure relate to compounds which have enhanced oral bioavailability. A transition metal complex includes a transition metal...
2017/0044192 ANTIVIRAL BETA-AMINO ACID ESTER PHOSPHODIAMIDE COMPOUNDS
Compounds of Formula I: ##STR00001## and their pharmaceutically acceptable salts are useful for the inhibition of HIV reverse transcriptase. The compounds may...
2017/0044191 Novel Prodrugs And Methods Of Use Thereof
The invention relates to compounds of use as targeted cytotoxic agents and methods of use thereof. In particular, the invention relates to prodrugs that are...
2017/0044190 INORGANIC SILOXANE LADDER COMPOSITES AND METHODS OF THEIR PREPARATION
Inorganic siloxane ladder polymers with metal-aza/thio crown complexes, and methods of making and using such siloxane ladder polymers are disclosed. The...
2017/0044189 COMPOSITIONS AND METHODS FOR IMPROVING GLUCOSE UPTAKE
A compound includes the structure of general Formula II, pharmaceutically acceptable salts thereof, and/or solvates thereof: ##STR00001## wherein R.sup.1,...
2017/0044187 1-(3-AMINOPROPYL) SUBSTITUTED CYCLIC AMINE COMPOUNDS, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL...
Provided are 1-(3-aminopropyl) substituted cyclic amine compounds as represented by formula (I), pharmaceutically acceptable salts, enantiomers,...
2017/0044186 HISTONE DEACETYLASE INHIBITORS
This invention relates to generally inhibiting histone deacetylase ("HDAC") enzymes (e.g., HDAC1, HDAC2, and HDAC3).
2017/0044185 Histone Deacetylase Inhibitors and Methods for Use Thereof
The present invention relates to methods of modulating (for example inhibiting) activity of histone deacetylases (HDACs) and/or treating HDACs--associated...
2017/0044184 NEW CRYSTAL FORM OF CEFATHIAMIDINE COMPOUND AND PREPARATION METHOD THEREFOR
A novel crystalline form of Cefathiamidine compound and its preparation method, characterizing in its X-ray powder diffraction pattern and differential...
2017/0044183 FACTOR XIa INHIBITORS
The present invention provides a compound of Formula (I) and pharmaceutical compositions comprising one or more said compounds, and methods for using said...
2017/0044182 FUSED MORPHOLINOPYRIMIDINES AND METHODS OF USE THEREOF
The present disclosure relates to Fused Morpholinopyrimidines, pharmaceutical compositions comprising an effective amount of a Fused Morpholinopyrimidine and...
2017/0044181 COMPOUNDS FOR TREATING VIRAL INFECTIONS
The present invention relates to small molecule compounds and their use in the treatment of diseases, in particular viral diseases, in particular hepatitis C...
2017/0044180 Sesquiterpenoids
The invention provides novel compounds and compositions for inhibiting IKK.alpha./.beta., including treating disorders associated with IKK.alpha./.beta....
2017/0044179 ALICYCLIC DIEPOXY COMPOUND HAVING BIS-SPIRONORBORNANE STRUCTURE, METHOD FOR PRODUCING THE SAME, AND USE THEREOF
An alicyclic diepoxy compound represented by the following general formula (1): ##STR00001## (in the general formula (1), R.sup.1 and R.sup.2 each independently ...
2017/0044178 POLYISOCYANATES FROM FUSED BICYCLIC POLYOLS AND POLYURETHANES THEREFROM
The present invention is directed to polyisocyanates and polyurethanes derived therefrom. In various embodiments, the present invention provides ...
2017/0044177 METHODS AND SYSTEMS FOR PRODUCING ISOSORBIDE FROM BIOMASS
Methods and systems for producing isosorbide from biomass are disclosed. In one embodiment, a method of producing isosorbide from biomass may include...
2017/0044176 CRYSTALLINE FORM OF TIOTROPIUM BROMIDE WITH LACTOSE
A cocrystal of tiotropium bromide and lactose monohydrate is herein disclosed. In the cocrystal the components tiotropium bromide and lactose are preferably...
2017/0044175 INHIBITORS OF LATE SV40 FACTOR (LSF) AS CANCER CHEMOTHERAPEUTICS
The present invention is directed to methods, compositions and kits for treatment of cancer, e.g. heptacellular carcinoma. In some embodiments, the present...
2017/0044174 HETEROCYCLIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
The present invention provides, in part, compounds of Formula (I): and pharmaceutically acceptable salts thereof; processes for the preparation of;...
2017/0044173 Orvinol and Thevinol Derivatives Useful in the Treatment of Drug and Alcohol Abuse, Depression, Anxiety, or a...
The invention provides a method of treating drug and alcohol abuse, depression, anxiety, or a compulsive disorder in a subject comprising administering to the...
2017/0044172 SPIRO UREA COMPOUNDS AS RSV ANTIVIRAL COMPOUNDS
The invention concerns novel substituted spiro urea azetidinyl or piperidinyl compounds of formula (I) having antiviral activity, in particular, having an...
2017/0044171 COMPOUNDS FOR PREPARING PYRROLE SIX-MEMBERED HETEROARYL RING DERIVATIVE
Intermediate compounds used in the preparation of pyrrole six-membered heteroaryl ring derivatives are disclosed. In particular, compounds of formula (IB) are...
2017/0044170 SOLID FORMS COMPRISING 1-ETHYL-7-(2-METHYL-6-(1H-1,2,4-TRIAZOL-3-YL)PYRIDIN-3-YL)-3,4-DIHYDROPYR- ...
Provided herein are formulations, processes, solid forms and methods of use relating to ...
2017/0044169 Pyrrolo[3,2-d]pyrimidine derivatives for the treatment of viral infections and other diseases
This invention concerns pyrrolo[3,2-d]pyrimidine derivatives, processes for their preparation, pharmaceutical compositions, and their use in treatment and/or...
2017/0044168 COMPOUNDS AND COMPOSITIONS AS TOLL-LIKE RECEPTOR 7 AGONISTS
The invention provides a compounds, immunogenic compositions and pharmaceutical compositions comprising such compounds and methods of using such compounds to...
2017/0044167 SUBSTITUTED 2,4,5,6-TETRAHYDROPYRROLO[3,4-C]PYRAZOLE AND 4,5,6,7-TETRAHYDRO-2H-PYRAZOLO[4,3-C]PYRIDINE...
The invention provides a chemical entity of Formula (I), wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and X have any of the values described herein, and...
2017/0044166 NOVEL SALT OF FUSED PYRIMIDINE COMPOUND AND CRYSTAL THEREOF
Provided is a salt having a high selectivity to BTK and is useful as a drug ingredient for a pharmaceutical product. It has been found that fumarate of Compound A...
2017/0044165 PENTYLENETETRAZOLE DERIVATIVES
Provided are compounds having formula I: ##STR00001## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, R.sup.9, and R.sup.10 are...
2017/0044164 BICYCLIC FUSED PYRIMIDINE COMPOUNDS AS TAM INHIBITORS
This application relates to compounds of Formula I: ##STR00001## or pharmaceutically acceptable salts thereof, which are inhibitors of TAM kinases which are...
2017/0044163 CGRP RECEPTOR ANTAGONISTS
The present invention provides a compound of Formula II: ##STR00001## or a pharmaceutically acceptable salt thereof.
2017/0044162 Fused Pyrimidine-Based Hydroxamate Derivatives
The present invention relates to fused R.sup.1 pyrimidine-based hydroxamate compounds of formula (I), comprising a hydroxamate group, that are inhibitors of...
2017/0044161 TRICYCLIC COMPOUND AND JAK INHIBITOR
Novel tricyclic compounds which have JAK inhibitory activities are useful for prevention, treatment or improvement of autoimmune diseases, inflammatory...
2017/0044160 TETRACYCLINE COMPOUNDS
The present invention is directed to a compound represented by Structural Formula (I): ##STR00001## or a pharmaceutically acceptable salt thereof. The variables...
2017/0044159 7-OXO-1,6-DIAZABICYCLO[3.2.1 ]OCTANE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS
Compounds of Formula (I), their preparation, and use in preventing or treating a bacterial infection are disclosed. ##STR00001##
2017/0044158 DIFLUOROMETHYLENE COMPOUND
A compound having an URAT1 inhibitory activity, and an URAT1 inhibitor, a blood uric acid level-reducing agent and a pharmaceutical composition containing the...
2017/0044157 NEW COMPOUNDS I
The present invention relates to compounds of formula (I), ##STR00001## and their pharmaceutically acceptable salts, solvates, hydrates, geometrical isomers,...
2017/0044156 SUBSTITUTED SPIROPYRIDO[1,2-a]PYRAZINE DERIVATIVE AND MEDICINAL USE THEREOF AS HIV INTEGRASE INHIBITOR
Provided is a substituted spiropyrido[1,2-a]pyrazine derivative or a pharmaceutically acceptable salt thereof, which is useful as an anti-HIV agent. The...
2017/0044155 Geminal Substituted Aminobenzisoxazole Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors
The present invention relates to novel geminal substituted aminobenzisoxazole compounds, and pharmaceutical compositions of the same, that are suitable as...
2017/0044154 HETEROARYL PIPERIDINE AND HETEROARYL PIPERAZINE DERIVATIVES AS FUNGICIDES
Heteroarylpiperidine and -piperazine derivatives of the formula (I) ##STR00001## in which the symbols A, X, Y, L.sup.1, L.sup.2, G, Q, p, R.sup.1, R.sup.2 and...
2017/0044153 HETEROARYL PIPERIDINE AND HETEROARYL PIPERAZINE DERIVATIVES AS FUNGICIDES
Heteroarylpiperidine and -piperazine derivatives of the formula (I) ##STR00001## in which the symbols A, X, Y, L.sup.1, L.sup.2, G, Q, p, R.sup.1, R.sup.2 and...
2017/0044152 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM
Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of store-operated calcium (SOC) channels....
2017/0044151 2-Amino-3-Fluoro-3-(Fluoromethyl)-6-Methyl-6-Phenyl-3,4,5,6-Tetrahydropyri- dines as BACE1 Inhibitors
The present invention provides compounds of Formula I ##STR00001## for the treatment of neurodegenerative or cognitive diseases. The method further provides for...
2017/0044150 IDENTIFICATION OF COMPOUNDS WHICH INHIBIT ATG8-ATG3 PROTEIN-PROTEIN INTERACTION AND THEIR USE AS...
The present invention provides compounds or a pharmaceutically acceptable salts, solvates, stereoisomers, or prodrugs thereof which can block the Atg8-Atg3...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.